Document is current
Any future updates will be listed below
-
Authors
Morioka, Shin
Nakanishi, Hiroki
Yamamoto, Toshiyoshi
Hasegawa, Junya https://orcid.org/0000-0003-1216-7468
Tokuda, Emi https://orcid.org/0000-0002-3837-4994
Hikita, Tomoya
Sakihara, Tomoko
Kugii, Yuuki
Oneyama, Chitose https://orcid.org/0000-0002-5719-9431
Yamazaki, Masakazu https://orcid.org/0000-0003-0050-0462
Suzuki, Akira
Sasaki, Junko
Sasaki, Takehiko https://orcid.org/0000-0003-1837-3748
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (18J21777, 26670132, 15H04693, 20H04920, 26253006, 15H05899, 17H03980, 20H03433, 15H04693)
Japan Agency for Medical Research and Development (18gm0710002h0006)
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 4 November 2020
Accepted: 2 December 2021
First Online: 10 January 2022
Competing interests
: H.N., J.S., and T.S. have filed for a patent (appl. No. 2018–528909), related to data in this paper on the phosphoinositide measurement method, which is under review. H.N serves as the CEO of and holds equity in LIPIDOME LAB Co., Ltd. T.S. is the founder of Japan Lipid Technologies, LLC. T.Y. serves as the CEO of Japan Lipid Technologies, LLC. The remaining authors declare no competing interests.
